A non-ST segment elevation myocardial infarction, also called an NSTEMI or a non-STEMI, is a type of heart attack. While it's often less damaging to your heart than a STEMI, it's still a serious ...
SAN FRANCISCO, California — A small, phase 2 study, with a biomarker test for its primary end point, offers some encouraging hints that the P-selectin antagonist inclacumab may be able to reduce ...
Sophia Antipolis, 19 Nov. 2015: Thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with non-ST-elevation myocardial infarction ...
In patients with non-ST-elevation myocardial infarction (NSTEMI) and frailty, an initial invasive strategy caused early harm followed by late benefit, resulting in a neutral effect on survival at 3 ...
CABG, surgery Patients with vs without chronic kidney disease have 32% lower odds of undergoing invasive cardiac procedures for acute coronary syndrome in adjusted analyses. Patients with chronic ...
The benefit of complete revascularization in older patients (≥75 years of age) with myocardial infarction and multivessel disease remains unclear. In this multicenter, randomized trial, we assigned ...
NOTE: TCTMD previously retracted this story after learning of concerns about the mortality endpoint used in the analysis. We have now, based on an amended abstract and slides submitted to the TCT ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback